AstraZeneca
NEWS
Days after the U.S. FDA greenlit the restart of AstraZeneca’s Phase III COVID-19 vaccine trial, the company said the preventative medication boosts immune responses in older and younger adults against the novel coronavirus.
After nearly a month in limbo, AstraZeneca will resume Phase III testing of its COVID-19 vaccine candidate in the United States.
It was another busy week for clinical trial updates and news. Here’s a look.
Shares of AstraZeneca dropped slightly Wednesday afternoon following reports that a patient participating in the Brazilian arm of the company’s global Phase III study has died.
The U.S. arm of the trial has been paused for more than a month while the U.S. Food and Drug Administration investigates a serious illness that occurred in a patient who received the experimental treatment.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 20, 2020.
It was another busy week for both COVID-19-related clinical trial news as well as trial updates for other indications. Here’s a look.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 13, 2020.
AstraZeneca signed a deal with Operation Warp Speed, the U.S. government program to advance COVID-19 vaccines and therapeutics, for a monoclonal antibody cocktail.
JOBS
IN THE PRESS